Your browser doesn't support javascript.
loading
Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma.
Fujisawa, Yasuhiro; Yoshikawa, Shusuke; Minagawa, Akane; Takenouchi, Tatsuya; Yokota, Kenji; Uchi, Hiroshi; Noma, Naoki; Nakamura, Yasuhiro; Asai, Jun; Kato, Junji; Fujiwara, Susumu; Fukushima, Satoshi; Uehara, Jiro; Hoashi, Toshihiko; Kaji, Tatsuya; Fujimura, Taku; Namikawa, Kenjiro; Yoshioka, Manabu; Murao, Naoki; Ogata, Dai; Matsuyama, Kanako; Hatta, Naohito; Shibayama, Yoshitsugu; Fujiyama, Toshiharu; Ishikawa, Masashi; Yamada, Daisuke; Kishi, Akiko; Nakamura, Yoshiyuki; Shimiauchi, Takatoshi; Fujii, Kazuyasu; Fujimoto, Manabu; Ihn, Hironobu; Katoh, Norito.
Affiliation
  • Fujisawa Y; Japanese Melanoma Study Group, Tsukuba, Japan.
  • Yoshikawa S; Prognosis and Statistical Investigation Committee of the Japanese Skin Cancer Society, Kumamoto, Japan.
  • Minagawa A; Department of Dermatology, University of Tsukuba, Tsukuba, Japan.
  • Takenouchi T; Japanese Melanoma Study Group, Tsukuba, Japan.
  • Yokota K; Department of Dermatology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Uchi H; Japanese Melanoma Study Group, Tsukuba, Japan.
  • Noma N; Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan.
  • Nakamura Y; Japanese Melanoma Study Group, Tsukuba, Japan.
  • Asai J; Department of Dermatology, Niigata Cancer Center, Niigata, Japan.
  • Kato J; Japanese Melanoma Study Group, Tsukuba, Japan.
  • Fujiwara S; Department of Dermatology, University of Nagoya, Nagoya, Japan.
  • Fukushima S; Japanese Melanoma Study Group, Tsukuba, Japan.
  • Uehara J; Department of Dermatology, University of Kyushu, Fukuoka, Japan.
  • Hoashi T; Japanese Melanoma Study Group, Tsukuba, Japan.
  • Kaji T; Department of Dermatology, Osaka City University, Osaka, Japan.
  • Fujimura T; Japanese Melanoma Study Group, Tsukuba, Japan.
  • Namikawa K; Department of Dermatology, Saitama Medical University International Medical Center, Hidaka, Japan.
  • Yoshioka M; Japanese Melanoma Study Group, Tsukuba, Japan.
  • Murao N; Department of Dermatology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Ogata D; Japanese Melanoma Study Group, Tsukuba, Japan.
  • Matsuyama K; Department of Dermatology, Sapporo Medical University, Sapporo, Japan.
  • Hatta N; Japanese Melanoma Study Group, Tsukuba, Japan.
  • Shibayama Y; Department of Dermatology, Kobe University, Kobe, Japan.
  • Fujiyama T; Japanese Melanoma Study Group, Tsukuba, Japan.
  • Ishikawa M; Department of Dermatology and Plastic Surgery, Kumamoto University, Kumamoto, Japan.
  • Yamada D; Japanese Melanoma Study Group, Tsukuba, Japan.
  • Kishi A; Department of Dermatology, Asahikawa Medical University, Asahikawa, Japan.
  • Nakamura Y; Japanese Melanoma Study Group, Tsukuba, Japan.
  • Shimiauchi T; Department of Dermatology, Nippon Medical School, Bunkyo-ku, Japan.
  • Fujii K; Japanese Melanoma Study Group, Tsukuba, Japan.
  • Fujimoto M; Department of Dermatology, Okayama University Graduate School of Medicine, Okayama, Japan.
  • Ihn H; Japanese Melanoma Study Group, Tsukuba, Japan.
  • Katoh N; Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Cancer Med ; 8(5): 2146-2156, 2019 05.
Article in En | MEDLINE | ID: mdl-30932370
ABSTRACT

BACKGROUND:

The incidence of melanoma among those of an Asian ethnicity is lower than in Caucasians; few large-scale Asian studies that include follow-up data have been reported.

OBJECTIVES:

To investigate the clinical characteristics of Japanese patients with melanoma and to evaluate the prognostic factors.

METHODS:

Detailed patient information was collected from the database of Japanese Melanoma Study Group of the Japanese Skin Cancer Society. The American Joint Committee on Cancer seventh Edition system was used for TNM classification. The Kaplan-Meier method and Cox proportional hazards model were used to estimate the impact of clinical and histological parameters on disease-specific survival in patients with invasive melanoma.

RESULTS:

In total, 4594 patients were included in this analysis. The most common clinical type was acral lentiginous melanoma (40.4%) followed by superficial spreading melanoma (20.5%), nodular melanoma (10.0%), mucosal melanoma (9.5%), and lentigo maligna melanoma (8.1%). The 5-year disease-specific survival for each stage was as follows IA = 98.0%, IB = 93.9%, IIA = 94.8%, IIB = 82.4%, IIC = 71.8%, IIIA = 75.0%, IIIB = 61.3%, IIIC = 41.7%, and IV = 17.7%. Although multivariate analysis showed that clinical classifications were not associated with survival across all stages, acral type was an independent poor prognostic factor in stage IIIA.

CONCLUSIONS:

Our study revealed the characteristics of melanoma in the Japanese population. The 5-year disease-specific survival of each stage showed a similar trend to that of Caucasians. While clinical classification was not associated with survival in any stages, acral type was associated with poor survival in stage IIIA. Our result might indicate the aggressiveness of acral type in certain populations.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Melanoma Type of study: Prognostic_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Cancer Med Year: 2019 Document type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Melanoma Type of study: Prognostic_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Cancer Med Year: 2019 Document type: Article Affiliation country: Japan